Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001285586 | SCV001472046 | pathogenic | Hereditary factor VIII deficiency disease | 2020-07-20 | criteria provided, single submitter | clinical testing | The F8 c.1202G>A; p.Trp401Ter variant is reported in an individual affected with hemophilia A with negligible F8 activity (see link to F8 database). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Additionally, another variant leading to the same nonsense change (c.1203G>A; p.Trp401Ter) has been reported in individuals with hemophilia A and is considered disease-causing (Ahmed 2005, see linked to F8 database). Based on available information, the c.1202G>A; p.Trp401Ter variant is considered to be pathogenic. References: Link to F8 database: http://f8-db.eahad.org/ Ahmed RP et al. Identification of 32 novel mutations in the factor VIII gene in Indian patients with hemophilia A. Haematologica. 2005;90(2):283-284. |